NASDAQ:ISPC

iSpecimen (ISPC) Stock Price, News & Analysis

$0.28
-0.02 (-6.72%)
(As of 04/24/2024 ET)
Today's Range
$0.27
$0.30
50-Day Range
$0.21
$0.48
52-Week Range
$0.20
$1.89
Volume
281,532 shs
Average Volume
679,956 shs
Market Capitalization
$2.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISPC stock logo

About iSpecimen Stock (NASDAQ:ISPC)

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

ISPC Stock Price History

ISPC Stock News Headlines

The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Nvidia GTC AI conference: What to watch
iSpecimen Full Year 2023 Earnings: Misses Expectations
iSpecimen Inc: iSpecimen Reports Full Year 2023 Results
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
iSpecimen Reports Full Year 2023 Results
iSpecimen: Q4 Earnings Insights
Fed rate cuts likely coming after June -strategist
iSpecimen Inc ISPC
See More Headlines
Receive ISPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2024
Today
4/25/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:ISPC
Fax
N/A
Employees
53
Year Founded
N/A

Profitability

Net Income
$-11,100,000.00
Net Margins
-111.81%
Pretax Margin
-111.79%

Debt

Sales & Book Value

Annual Sales
$9.93 million
Book Value
$1.07 per share

Miscellaneous

Free Float
6,309,000
Market Cap
$2.60 million
Optionable
Not Optionable
Beta
1.69
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Ms. Tracy Wilson Curley (Age 62)
    CEO, CFO, Treasurer & Director
    Comp: $437.5k
  • Mr. Benjamin Bielak (Age 54)
    Chief Information Officer & Secretary
    Comp: $391.2k
  • Ms. Carly Lejnieks
    Vice President of Marketing
  • Ms. Annette Arnold
    Vice President of Sales & Business Development
  • Mr. David Wages M.D.
    Ph.D., Chief Medical Officer
  • Mr. Eric Langlois
    Chief Revenue Officer
  • Mr. Evan Cox
    Senior Vice President of Strategy & Innovation

ISPC Stock Analysis - Frequently Asked Questions

How have ISPC shares performed in 2024?

iSpecimen's stock was trading at $0.5006 at the beginning of the year. Since then, ISPC shares have decreased by 44.5% and is now trading at $0.2778.
View the best growth stocks for 2024 here
.

Are investors shorting iSpecimen?

iSpecimen saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 459,500 shares, an increase of 2,826.8% from the March 15th total of 15,700 shares. Based on an average trading volume of 145,700 shares, the days-to-cover ratio is presently 3.2 days. Approximately 8.6% of the shares of the stock are short sold.
View iSpecimen's Short Interest
.

When is iSpecimen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ISPC earnings forecast
.

How were iSpecimen's earnings last quarter?

iSpecimen Inc. (NASDAQ:ISPC) announced its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.34) EPS for the quarter. The business earned $2.58 million during the quarter. iSpecimen had a negative net margin of 111.81% and a negative trailing twelve-month return on equity of 80.37%.

When did iSpecimen IPO?

iSpecimen (ISPC) raised $20 million in an initial public offering (IPO) on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) served as the underwriter for the IPO.

How do I buy shares of iSpecimen?

Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ISPC) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners